|Last Price||Today's Change||52-Week Range||Trading Volume|
|36.92||-0.26 (-0.70%)||32.35 - 55.99||1.3 million (Above Avg)|
Market data as of 3:59PM 10/01/14. Quotes are delayed by at least 15 min.
Seattle Genetics Highlights Updated Progression-Free Survival and Overall Survival Data from ADCETRIS® (Brentuximab Vedotin) Frontline PTCL Phase 1 Clinical Trial at the ESMO 2014 Congress
09/24/2014 9:00 AM ET